Cargando…
EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643397/ https://www.ncbi.nlm.nih.gov/pubmed/33153494 http://dx.doi.org/10.1186/s40478-020-01056-8 |
| _version_ | 1783606272519569408 |
|---|---|
| author | Antin, C. Tauziède-Espariat, A. Debily, M.-A. Castel, D. Grill, J. Pagès, M. Ayrault, O. Chrétien, F. Gareton, A. Andreiuolo, F. Lechapt, E. Varlet, P. |
| author_facet | Antin, C. Tauziède-Espariat, A. Debily, M.-A. Castel, D. Grill, J. Pagès, M. Ayrault, O. Chrétien, F. Gareton, A. Andreiuolo, F. Lechapt, E. Varlet, P. |
| author_sort | Antin, C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7643397 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76433972020-11-06 EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression Antin, C. Tauziède-Espariat, A. Debily, M.-A. Castel, D. Grill, J. Pagès, M. Ayrault, O. Chrétien, F. Gareton, A. Andreiuolo, F. Lechapt, E. Varlet, P. Acta Neuropathol Commun Letter to the Editor BioMed Central 2020-11-05 /pmc/articles/PMC7643397/ /pubmed/33153494 http://dx.doi.org/10.1186/s40478-020-01056-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Letter to the Editor Antin, C. Tauziède-Espariat, A. Debily, M.-A. Castel, D. Grill, J. Pagès, M. Ayrault, O. Chrétien, F. Gareton, A. Andreiuolo, F. Lechapt, E. Varlet, P. EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression |
| title | EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression |
| title_full | EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression |
| title_fullStr | EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression |
| title_full_unstemmed | EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression |
| title_short | EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression |
| title_sort | ezhip is a specific diagnostic biomarker for posterior fossa ependymomas, group pfa and diffuse midline gliomas h3-wt with ezhip overexpression |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643397/ https://www.ncbi.nlm.nih.gov/pubmed/33153494 http://dx.doi.org/10.1186/s40478-020-01056-8 |
| work_keys_str_mv | AT antinc ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression AT tauziedeespariata ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression AT debilyma ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression AT casteld ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression AT grillj ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression AT pagesm ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression AT ayraulto ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression AT chretienf ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression AT garetona ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression AT andreiuolof ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression AT lechapte ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression AT varletp ezhipisaspecificdiagnosticbiomarkerforposteriorfossaependymomasgrouppfaanddiffusemidlinegliomash3wtwithezhipoverexpression |